BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14658124)

  • 21. Warfarin therapy in patients with venous thromboembolism: patterns of use and predictors of clinical outcomes.
    Deitelzweig SB; Lin J; Kreilick C; Hussein M; Battleman D
    Adv Ther; 2010 Sep; 27(9):623-33. PubMed ID: 20680533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged warfarin thwarts return of clots.
    Health News; 2003 May; 9(5):6-7. PubMed ID: 12739456
    [No Abstract]   [Full Text] [Related]  

  • 23. [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].
    Schulman S
    Lakartidningen; 2003 Jun; 100(24):2118-21. PubMed ID: 12841107
    [No Abstract]   [Full Text] [Related]  

  • 24. Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.
    Koscielny J; Kiesewetter H; Jörg I; Harenberg J
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):299-307. PubMed ID: 17636192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low-dose warfarin for prevention of symptomatic thromboembolism after orthopedic surgery.
    Enyart JJ; Jones RJ
    Ann Pharmacother; 2005 Jun; 39(6):1002-7. PubMed ID: 15886295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term standard-dose warfarin to prevent thrombosis.
    Depenbrock PJ
    Am Fam Physician; 2005 Jul; 72(1):36, 41. PubMed ID: 16035681
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 28. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation period in idiopathic venous thromboembolism. How long is enough?
    Farraj RS
    Saudi Med J; 2004 Jul; 25(7):848-51. PubMed ID: 15235686
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism.
    Tran H; McRae S; Ginsberg J
    Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of venous thromboembolism in perioperative period].
    Nakamura M
    Masui; 2007 Jul; 56(7):787-93. PubMed ID: 17633838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimal initial dose adjustment of warfarin in orthopedic patients.
    Lenzini PA; Grice GR; Milligan PE; Gatchel SK; Deych E; Eby CS; Burnett RS; Clohisy JC; Barrack RL; Gage BF
    Ann Pharmacother; 2007 Nov; 41(11):1798-804. PubMed ID: 17911206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose warfarin coupled with lower leg compression is effective prophylaxis against thromboembolic disease after hip arthroplasty.
    Bern M; Deshmukh RV; Nelson R; Bierbaum B; Sevier N; Howie N; Losina E; Katz JN
    J Arthroplasty; 2007 Aug; 22(5):644-50. PubMed ID: 17689770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence-based initiation of warfarin (Coumadin).
    Ebell MH
    Am Fam Physician; 2005 Feb; 71(4):763-5. PubMed ID: 15742915
    [No Abstract]   [Full Text] [Related]  

  • 36. Evidence-based adjustment of warfarin (Coumadin) doses.
    Ebell MH
    Am Fam Physician; 2005 May; 71(10):1979-82. PubMed ID: 15926414
    [No Abstract]   [Full Text] [Related]  

  • 37. [Advice for patients taking oral anticoagulants (coumadin or Previscan)].
    Rev Prat; 2007 Apr; 57(7):768. PubMed ID: 17626322
    [No Abstract]   [Full Text] [Related]  

  • 38. Mars or venus--is sex a risk factor for recurrent venous thromboembolism?
    Elliott CG; Rubin LJ
    N Engl J Med; 2004 Jun; 350(25):2614-6. PubMed ID: 15201419
    [No Abstract]   [Full Text] [Related]  

  • 39. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
    Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
    Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-dimer and duration of anticoagulation.
    Glynn RJ; Goldhaber SZ; Ridker PM
    N Engl J Med; 2007 Jan; 356(4):422-3; author reply 423. PubMed ID: 17256206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.